TAK-259 is a novel, selective, and orally active α1D adrenergic receptor antagonist (α1D, Ki = 1.1 nM) that represents a promising new therapeutic agent for the treatment of symptoms of OAB. It has an anti-frequency effect and reduces the burden of the human Ether-a-Go-Go-Related gene (HERG).
TAK-259 HCl
还可以
产品编号 T34774 别名 TAK-259, TAK259Cas号 1192347-42-4
TAK-259 is a novel, selective, and orally active α1D adrenergic receptor antagonist (α1D, Ki = 1.1 nM) that represents a promising new therapeutic agent for the treatment of symptoms of OAB. It has an anti-frequency effect and reduces the burden of the human Ether-a-Go-Go-Related gene (HERG).
TAK-259 is a novel, selective, and orally active α1D adrenergic receptor antagonist (α1D, Ki = 1.1 nM) that represents a promising new therapeutic agent for the treatment of symptoms of OAB. It has an anti-frequency effect and reduces the burden of the human Ether-a-Go-Go-Related gene (HERG).
别名
TAK-259, TAK259
化学信息
分子量
410.7
分子式
C14H14Cl3N3O3S
CAS No.
1192347-42-4
密度
no data available
储存&溶解度
存储
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
评论内容